Cargando…

Use of Budesonide in the Treatment of Microscopic Colitis

Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tangri, Vikram, Chande, Nilesh
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003217/
https://www.ncbi.nlm.nih.gov/pubmed/20616427
http://dx.doi.org/10.4103/1319-3767.65188
_version_ 1782193839194243072
author Tangri, Vikram
Chande, Nilesh
author_facet Tangri, Vikram
Chande, Nilesh
author_sort Tangri, Vikram
collection PubMed
description Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in both collagenous colitis and lymphocytic colitis. Budesonide is effective as a maintenance drug for patients with collagenous colitis, but has not been studied for this indication in patients with lymphocytic colitis. This drug improves quality of life in patients while causing few mild adverse events. Budesonide is an effective treatment of microscopic colitis that is safe and well tolerated.
format Text
id pubmed-3003217
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30032172010-12-23 Use of Budesonide in the Treatment of Microscopic Colitis Tangri, Vikram Chande, Nilesh Saudi J Gastroenterol In Focus Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in both collagenous colitis and lymphocytic colitis. Budesonide is effective as a maintenance drug for patients with collagenous colitis, but has not been studied for this indication in patients with lymphocytic colitis. This drug improves quality of life in patients while causing few mild adverse events. Budesonide is an effective treatment of microscopic colitis that is safe and well tolerated. Medknow Publications 2010-07 /pmc/articles/PMC3003217/ /pubmed/20616427 http://dx.doi.org/10.4103/1319-3767.65188 Text en © The Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle In Focus
Tangri, Vikram
Chande, Nilesh
Use of Budesonide in the Treatment of Microscopic Colitis
title Use of Budesonide in the Treatment of Microscopic Colitis
title_full Use of Budesonide in the Treatment of Microscopic Colitis
title_fullStr Use of Budesonide in the Treatment of Microscopic Colitis
title_full_unstemmed Use of Budesonide in the Treatment of Microscopic Colitis
title_short Use of Budesonide in the Treatment of Microscopic Colitis
title_sort use of budesonide in the treatment of microscopic colitis
topic In Focus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003217/
https://www.ncbi.nlm.nih.gov/pubmed/20616427
http://dx.doi.org/10.4103/1319-3767.65188
work_keys_str_mv AT tangrivikram useofbudesonideinthetreatmentofmicroscopiccolitis
AT chandenilesh useofbudesonideinthetreatmentofmicroscopiccolitis